A Comparison of the Humoral Immune Response Induced by a Recombinant Human Protein in Wild Type Mice and in Transgenic Mice Expressing the Protein
Journal Title: Journal of Pharmaceutical Research International - Year 2014, Vol 4, Issue 21
Abstract
Aim: The aim of this work was to investigate the correlation between anti drug antibody (ADA) induction and how different manufacturing processes of biopharmaceuticals affect the immunogenicity of the protein. This was done by testing four different batches of the same recombinant human protein in transgenic (Tg) mice. Methodology: Wild type (Wt) and human protein-transgenic (Tg) mice were challenged by repeated subcutaneous injections of four batches of a drug candidate protein, obtained by different purification methods. Differences between drug-specific IgG1, IgG2a, IgG2b, IgG3 and IgM antibody patterns produced in Tg vs. Wt mice were investigated and compared to the plasma cytokine profiles. A conventional ELISA was used as a reference method for ADA detection. Results: ADA responses detected in Tg mice were mainly of the IgG1 subclass and occurred only in significant response to the batch containing the highest level of proteins originating from the recombinant host cells. Wt mice, on the other hand, showed a combined IgG1/IgG2b response to all drug batches, except to the batch with the highest purity. The most pure batch failed to induce significant ADA in both Wt and Tg animals, suggesting host cell derived impurities to be a strong contributing factor to the antibody responses observed. Conclusion: Thus, an isolated IgG1 response in drug-tolerant Tg mice may serve as a potential biomarker of an immunological reaction to process-related impurities of the protein drug. In contrast, a combined IgG1/IgG2b-profile, as observed in immunoreactive Wt mice, more likely reflects a xeno-response.
Authors and Affiliations
Britta Granath, Jan Holgersson, Karin Cederbrant, Ann Lövgren, Nina Brenden
Pharmacist Perceived Barriers to Patient Counseling; A Study in Eastern Region of Saudi Arabia
Background: Pharmaceutical care model (PCM) is the philosophy of practice that includes identifying and resolving medication therapy problems to improve patient outcomes. Patient counseling by a pharmacist is a fundament...
Regulatory Aspects of Omega Polyunsaturated Fatty Acids in Dietary Supplements
Background: Food additives are subject to certain regulatory requirements, as in some countries, the control is very strict, while in others there is almost no control. Some food supplements can affect existing diseases...
Derivatisation of Cashew Gum by Esterification Using Citric Acid and Glycerol
Citric acid and glycerol were used to derivatise cashew gum via cross-linking. A dispersion of the purified gum, the acid, glycerol and sodium dihydrogen phosphate was made in deionised water and concentrated by heating...
An Assessment of the Level of Awareness, Attitudes, Opinions of Pharmacy Students Concerning HIV and AIDS in Malaysia
Aims: HIV and AIDS spreading wide and causing serious threats and deaths among Malaysian residents. A nationwide cross-sectional survey was conducted to assess the awareness, attitudes and opinions about HIV and AIDS amo...
Evaluation of C. cassia Effectiveness in Behavioral Modulation of Haloperidol Induced Parkinson’s Disease (Mice Model)
Aims: This study was undertaken to evaluate the effectiveness of behavioral modulation of C. cassia extract against Haloperidol induced Parkinson’s disease (PD) in albino mice. Study Design: The study used...